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Rat IL-18 was cloned from cDNA from the brains of rats treated with lipopolysaccharide (LPS). Rat IL-18 was successfully amplified by PCR using primers based on the mouse IL-18 sequence. Different combinations of primers designed outside the coding region of murine IL-18 (Table 1 ) and a range of annealing temperatures (44-60°C) facilitated cloning. Primer pairs A and C amplified products of the predicted length, which identified IL-18 positive on Southern blot. Recloning using rat IL-18 specific primers and direct sequencing (see Methods) verified the initial sequence data. Rat IL-18 was shown to be homologous to mouse (90.9%) and human (72.7%) IL-18 cDNA. Rat IL-18 has a 585-bp coding sequence with a predicted protein of 194 (22.3 kDa) residues with a pI of 4.7. Rat brain IL-18 has 98% homology to rat adrenal gland IL-18 but it has three semi-conservative amino acid changes. 6 An IL-18 species amino acid alignment of human, mouse and rat IL-18 is shown in Figure 1 , in which the IL-1 signature (F X 12 F X S X 6 F L) in IL-18 is highlighted. IL-18 does not possess any other currently recognised motifs. The IL-18 cDNA like IL-1␣ and IL-1␤, does not encode a hydrophobic signal peptide to enable secretion from the cell and therefore its mechanism of release is unknown.
To simplify the purification and detection of expressed protein, both the inactive pro-IL-18 and mature length IL-18 were expressed in DH5␣ E. coli using the FLAG expression system (Kodak/IBI), which contained an eight residue N terminal tag to the expressed IL-18 protein. Pro-IL-18 and mature length IL-18 were expressed in the vectors pMAC-FLAG and pATS-FLAG; the latter contains an OMP A (outer membrane protein A) sequence which directs protein secretion. However protein expression levels were lower with this vector. Full-length and mature pMAC-IL-18 protein were induced in DH5␣ E. coli with IPTG, and the expressed proteins were purified by affinity chromatography.
Caspase-1 (interleukin-1␤ converting enzyme, ICE) is a member of the growing caspase family and was first identified with a specificity for Asp-X cleavage essential in IL-1␤ activation. 8 Biologically active mouse IL-18 is produced by caspase-1 cleavage at Asp35-Asn36 3,7 (highlighted in Figure 1 ). By alignment, the putative cleavage site of rat IL-18, Asp-His, should also be cleaved by caspase-1. We demonstrate that recombinant human caspase-1 cleaves recombinant rat pro-IL-18 in vitro to produce cleavage products of the molecular weight corresponding to mature IL-18 and that this cleavage was inhibited by the caspase inhibitor zVAD-DCB ( Figure 2) . The results shown are representative of five independent experiments each of which produced the same pattern of caspase-1 cleavage. The control recombinant human pro-IL-1␤ was also cleaved by caspase-1, and zVAD-DCB prevented this maturation of IL-1␤ (Figure 2 ).
The expression of IL-18 was examined by RT-PCR using RNA extracted from rat cerebellum, hippocampus, hypothalamus, cortex or striatum. IL-18 expression was detected in each of these brain regions in normal, untreated (uncannulated) rats. Figure 3 shows RT-PCR product intensities obtained for one set of brain samples obtained from one rat. RT-PCR was performed in triplicate in each brain sample. This pattern of expression is representative of results obtained from two independent experiments, each with one rat per data point. To ensure that this product was not derived from contaminating peripheral blood cells, IL-18 expression was compared in unperfused and saline perfused animals. The same pattern of IL-18 expression was observed in each brain region (data not shown). In a separate study, IL-18 expression was demonstrated in primary cell cultures of microglia and astrocytes prepared from untreated brain (data not shown).
Functional characterisation of this novel cytokine is in its infancy, though it appears that IL-18 and IL-1␤ have different cellular targets and contrasting cytokine profiles.
1,5 IL-18 activates NK cells and cytotoxic T cells, 3, 5, 9 and appears to have anti-tumour properties.
9
In vitro IL-18 induces IFN␥, 3,5 GM-CSF 5 and inhibits IL-10 and IL-2 production. 5, 9 It synergises with IL-12 enhancing IFN␥ production in T cells, B cells, NK cells and macrophages. [10] [11] [12] [13] Although IL-18 actions in vivo are not well characterised, anti-IL-18 antibody pretreatment dramatically reduces endotoxin-induced liver injury in BALB/c nude mice, 3, 14 and attenuates IFN␥ and late TNF␣ induction, as well as FasL and TNG␣-mediated death in these mice.
14 IL-18 has also been implicated in allergic reaction 13 and diabetes progression, 15 suggesting that it could mediate a number of biological and pathological responses.
Recent evidence suggests that IL-18 is an IL-1 related cytokine. IL-18 shares protein homology with IL-1␤ (19%) and IL-1ra (12%) in the twelve ␤ sheet motif, which is important for receptor binding. 1, 4, 16 Indeed, it has recently been demonstrated that IL-1 receptor related protein (IL-1Rrp), originally cloned by PCR using degenerate primers designed on the IL-1 receptor, 17 is an IL-18 receptor or accessory protein (AcP). 18 Moreover, IL-18 binding to IL-1Rrp, 18 and IL-1␤ binding to IL-1RI/IL-1Acp, 19, 20 activate similar signalling pathways in that they signal through IL-1 receptor associated kinase (IRAK) to induce activation of the transcription factor NF-B. 18 23 have reported that radiolabelled murine and human IL-1␤ and IL-18 are equally sensitive to proteolytic activation by caspase-1 cleavage. We confirm that rat FLAG tagged pro-IL-18 is also processed by caspase-1, and that the caspase inhibitor zVAD-DCB inhibits this cleavage. Although Kupffer cells from caspase-1 knockout mice produce similar levels of IL-18 protein as wild-type animals, the cells from the caspase −/− mice showed reduced export of mature IL-18, 7 indicating that caspase-1 is important in the release of mature IL-18. We have cloned IL-18 from rat brain and shown that IL-18 is expressed widely centrally. It is now important to identify the actions and role of this novel cytokine in the brain.
Methods
Adult, male, Sprague-Dawley rats (Charles River, UK) weighing between 250-300 g were housed at 21°C with free access to food and water. All experiments were performed in accordance with the UK Home Office Animals (Scientific Procedures) Act, 1986.
PCR cloning of rat brain IL-18
Guide cannulae were stereotaxically implanted into the lateral ventricle of the brain under halothane anaesthesia (2% in 2 litres min −1 oxygen) and rats were allowed to recover for one week. Rats were injected into the lateral cerebral ventricle (i.c.v.) with either 3 l of saline or LPS (9 g rat
−1
). Three hours later they were killed and their brains removed, snap frozen at −30°C in isopentane, and stored at −70°C.
Three pairs of PCR primers were derived from murine IL-18 sequence and were used to amplify rat IL-18 from reverse transcribed RNA extracted from these rat brains. The PCR primers were synthesised on an Applied Biosystems 392 DNA synthesiser and are described in Table 1 . One microgram of RNA was reverse transcribed with 200 units of Superscript II RNase H − reverse transcriptase (Gibco-BRL, Paisley, UK). Rat brain cDNA template was amplified using Expand Hi Fidelity Taq polymerase (Boehringer Mannheim, Sussex, UK). Thirty cycles of PCR were performed using a range of annealing temperatures 44-60°C at 2°C intervals.
Primer pair C amplified a product of the expected size, which was confirmed by southern blot (Table 1) and blunt end ligated into pBluescript SK+ (Stratagene) and sequenced (Sequenase, Amersham, Bucks, UK). Rat IL-18 was reamplified from rat brain cDNA with PCR primers derived from the primary clones. Clones amplified from several separate PCR reactions were sequenced to confirm all data. The cloned PCR product was found to be 90.9% homologous to the published mouse IL-18 sequence. This sequence has been submitted to Genbank and the accession number is AJ222813.
Expression and purification of FLAG epitope-tagged IL-18
The full length and the putative mature length rat IL-18 clones were ligated into HindIII (Boehringer Mannheim) restriction site after the FLAG sequence in pFLAG-Mac and pFLAG-ATS (Kodak/IBI, Herts, UK) expression vectors. Protein was induced with 500 M IPTG (Sigma, Dorset, UK) for 3.5 h at 37°C, the cells were harvested, lysed and IL-18 protein was purified by affinity chromatography on an M2 anti-FLAG affinity chromatography column (Kodak/IBI). Purified protein was analysed by SDS PAGE on silver-stained gels and quantified by protein assay (Biorad, Herts, UK).
RT-PCR analysis of IL-18 expression in rat brain
RNA was extracted from untreated rat brains using Trizol (Gibco-BRL), 1 g of RNA was reverse transcribed to cDNA with EXPAND reverse transcriptase (Boehringer Mannheim) and IL-18 was amplified by 30 cycles of PCR using taq polymerase (Perkin Elmer, Cheshire, UK) with PCR primers D ( Table 1 ). The PCR products resolved on a 1% agarose gel stained with 0.5 g ml −1 ethidium bromide and visualised under UV light.
In vitro cleavage assay
One hundred nanograms of recombinant human pro-IL-1␤ (Cistron, UK) or rat pro-IL-18, with or without the caspase-1 inhibitor zVAD-DCB (1 M, 100 M) were pre-incubated at 37°C for 30 min, in 25 l caspase-1 reaction buffer (100 mM HEPES, pH 7.5, 10% sucrose, 0.1% CHAPS, 0.1 mM EDTA). Fifty to 500 U of recombinant human caspase-1 and 10 mM DTT, required for enzyme activation, were then added. The reaction volume was made to 50 l with caspase-1 reaction buffer and the cleavage assay was incubated at 25°C for 30 min. The products were analysed on silverstained SDS PAGE gels (14% Tris glycine) or immunologically detected.
Immunological detection of IL-18 and IL-1␤
IL-18 and IL-1␤ (Cistron) were detected by ECL (Amersham) with 10 g ml −1 M2 anti-FLAG monoclonal antibody (Sigma), 0.5 l ml −1 goat anti-mouse IgG-HRP secondary (Sigma) and 4 l ml −1 sheep antihuman IL-1␤ monoclonal antibody (Zeneca Pharmaceuticals), 0.5 l ml −1 rabbit anti-sheep IgG-HRP secondary (Dako) respectively. The M2 anti-FLAG monoclonal antibody recognised the FLAG amino residues contained in recombinant pro-IL-18 or mature IL-18, and therefore was unable to detect the cleaved unlabelled IL-18.
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